Literature DB >> 20631810

Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis.

Adam M Guss1, Guus Roeselers, Irene L G Newton, C Robert Young, Vanja Klepac-Ceraj, Stephen Lory, Colleen M Cavanaugh.   

Abstract

In patients afflicted with cystic fibrosis (CF), morbidity and mortality are primarily associated with the adverse consequences of chronic microbial bronchial infections, which are thought to be caused by a few opportunistic pathogens. However, recent evidence suggests the presence of other microorganisms, which may significantly affect the course and outcome of the infection. Using a combination of 16S rRNA gene clone libraries, bacterial culturing and pyrosequencing of barcoded 16S rRNA amplicons, the microbial communities present in CF patient sputum samples were examined. In addition to previously recognized CF pathogens such as Pseudomonas aeruginosa and Staphylococcus aureus, >60 phylogenetically diverse bacterial genera that are not typically associated with CF pathogenesis were also detected. A surprisingly large number of fermenting facultative and obligate anaerobes from multiple bacterial phyla was present in each sample. Many of the bacteria and sequences found were normal residents of the oropharyngeal microflora and with many containing opportunistic pathogens. Our data suggest that these undersampled organisms within the CF lung are part of a much more complex microbial ecosystem than is normally presumed. Characterization of these communities is the first step in elucidating potential roles of diverse bacteria in disease progression and to ultimately facilitate advances in CF therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20631810      PMCID: PMC3105664          DOI: 10.1038/ismej.2010.88

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  58 in total

1.  Defining the normal bacterial flora of the oral cavity.

Authors:  Jørn A Aas; Bruce J Paster; Lauren N Stokes; Ingar Olsen; Floyd E Dewhirst
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

2.  Diversity of the human intestinal microbial flora.

Authors:  Paul B Eckburg; Elisabeth M Bik; Charles N Bernstein; Elizabeth Purdom; Les Dethlefsen; Michael Sargent; Steven R Gill; Karen E Nelson; David A Relman
Journal:  Science       Date:  2005-04-14       Impact factor: 47.728

3.  Microbial diversity in the sputum of a cystic fibrosis patient studied with 16S rDNA pyrosequencing.

Authors:  F Armougom; F Bittar; N Stremler; J-M Rolain; C Robert; J-C Dubus; J Sarles; D Raoult; B La Scola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-16       Impact factor: 3.267

4.  Bias in template-to-product ratios in multitemplate PCR.

Authors:  M F Polz; C M Cavanaugh
Journal:  Appl Environ Microbiol       Date:  1998-10       Impact factor: 4.792

Review 5.  The innate immune system in cystic fibrosis lung disease.

Authors:  R Bals; D J Weiner; J M Wilson
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  The pathogenesis of human periodontitis: an introduction.

Authors:  R C Page; K S Kornman
Journal:  Periodontol 2000       Date:  1997-06       Impact factor: 7.589

Review 7.  Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.

Authors:  B Tümmler; C Kiewitz
Journal:  Mol Med Today       Date:  1999-08

8.  Membrane vesicles traffic signals and facilitate group activities in a prokaryote.

Authors:  Lauren M Mashburn; Marvin Whiteley
Journal:  Nature       Date:  2005-09-15       Impact factor: 49.962

9.  Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture.

Authors:  Lauren M Mashburn; Amy M Jett; Darrin R Akins; Marvin Whiteley
Journal:  J Bacteriol       Date:  2005-01       Impact factor: 3.490

Review 10.  Human polymicrobial infections.

Authors:  Kim A Brogden; Janet M Guthmiller; Christopher E Taylor
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

View more
  85 in total

1.  Analysis of changes in diversity and abundance of the microbial community in a cystic fibrosis patient over a multiyear period.

Authors:  Joshua R Stokell; Raad Z Gharaibeh; Timothy J Hamp; Malcolm J Zapata; Anthony A Fodor; Todd R Steck
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

Review 2.  Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.

Authors:  Geraint B Rogers; Kenneth D Bruce
Journal:  Mol Diagn Ther       Date:  2010-12-01       Impact factor: 4.074

3.  Species-Level Identification of Actinomyces Isolates Causing Invasive Infections: Multiyear Comparison of Vitek MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) to Partial Sequencing of the 16S rRNA Gene.

Authors:  T Lynch; D Gregson; D L Church
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

Review 4.  The role of the bacterial microbiome in lung disease.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

5.  Bacterial diversity of surface sand samples from the Gobi and Taklamaken deserts.

Authors:  Shu An; Cécile Couteau; Fan Luo; Julie Neveu; Michael S DuBow
Journal:  Microb Ecol       Date:  2013-08-22       Impact factor: 4.552

6.  Chelation of Membrane-Bound Cations by Extracellular DNA Activates the Type VI Secretion System in Pseudomonas aeruginosa.

Authors:  Mike Wilton; Megan J Q Wong; Le Tang; Xiaoye Liang; Richard Moore; Michael D Parkins; Shawn Lewenza; Tao G Dong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

7.  Metabolite transfer with the fermentation product 2,3-butanediol enhances virulence by Pseudomonas aeruginosa.

Authors:  Arvind Venkataraman; Miriam A Rosenbaum; Jeffrey J Werner; Stephen C Winans; Largus T Angenent
Journal:  ISME J       Date:  2014-01-09       Impact factor: 10.302

Review 8.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

9.  Effect of sample storage conditions on culture-independent bacterial community measures in cystic fibrosis sputum specimens.

Authors:  Jiangchao Zhao; Jun Li; Patrick D Schloss; Linda M Kalikin; Tracy A Raymond; Joseph F Petrosino; Vincent B Young; John J LiPuma
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

Review 10.  Integrating the microbiota of the respiratory tract with the unified airway model.

Authors:  Alissa S Hanshew; Marie E Jetté; Sarah P Rosen; Susan L Thibeault
Journal:  Respir Med       Date:  2017-03-22       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.